Literature DB >> 17117490

Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France.

Christian H Roux1, Alain Saraux, Etienne Le Bihan, Patrice Fardellone, Patrice Guggenbuhl, Bruno Fautrel, Charles Masson, Isabelle Chary-Valckenaere, Alain Cantagrel, René Juvin, René-Marc Flipo, Lianna Euller-Ziegler, Joel Coste, Francis Guillemin.   

Abstract

OBJECTIVE: To determine geographical variation in the prevalence of rheumatoid arthritis (RA) and spondyloarthropathies (SpA) in France.
METHODS: The survey sample was drawn from 7 areas of France. Households were randomly selected using the national telephone directory, and an individual within each household was randomly chosen by the next-birthday method. All cases of suspected RA and SpA were confirmed by the patient's rheumatologist or by clinical examination. Standardized estimates of prevalence were compared between regions and groups of regions.
RESULTS: In total 15,219 anonymous telephone numbers were selected. An average response rate of 64% led to a total of 9395 respondents included in the study. The highest regional rates of RA were observed in the south (range 0.59-0.66%), and the lowest in the north (range 0.14-0.24%), with a national rate of 0.31% (95% CI 0.18-0.48%). Regional heterogeneity was observed for SpA, with the highest rates in Bretagne (0.47%) and the Sud-Est (0.53%) and a national rate of 0.30% (95% CI 0.17-0.46%).
CONCLUSION: This study is the largest of its kind conducted in France. It shows inter-regional variations, mainly in RA, with a higher prevalence in the south of the country. The many potential reasons for the heterogeneity observed, including genetic and environmental factors, warrant further research.

Entities:  

Mesh:

Year:  2006        PMID: 17117490

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

1.  The burden of disease in rheumatoid arthritis.

Authors:  Till Uhlig; Rikke H Moe; Tore K Kvien
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

2.  Sociodemographic and disease-related factors are associated with patient-reported anxiety and depression in spondyloarthritis patients in the Swedish SpAScania cohort.

Authors:  Jorit J L Meesters; Ingemar F Petersson; Stefan Bergman; Emma Haglund; Lennart T H Jacobsson; Ann Bremander
Journal:  Clin Rheumatol       Date:  2014-06-08       Impact factor: 2.980

3.  Welfare costs in patients with rheumatoid arthritis and their partners compared with matched controls: a register-based study.

Authors:  Katrine Løppenthin; Bente Appel Esbensen; Mikkel Østergaard; Rikke Ibsen; Jakob Kjellberg; Poul Jennum
Journal:  Clin Rheumatol       Date:  2016-10-25       Impact factor: 2.980

Review 4.  Global epidemiology of rheumatoid arthritis.

Authors:  Axel Finckh; Benoît Gilbert; Bridget Hodkinson; Sang-Cheol Bae; Ranjeny Thomas; Kevin D Deane; Deshiré Alpizar-Rodriguez; Kim Lauper
Journal:  Nat Rev Rheumatol       Date:  2022-09-06       Impact factor: 32.286

5.  Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis.

Authors:  C Trocmé; H Marotte; A Baillet; B Pallot-Prades; J Garin; L Grange; P Miossec; J Tebib; F Berger; M J Nissen; R Juvin; F Morel; P Gaudin
Journal:  Ann Rheum Dis       Date:  2008-07-29       Impact factor: 19.103

Review 6.  Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review.

Authors:  Nurullah Akkoc
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

Review 7.  Undifferentiated spondyloarthritis: a global perspective.

Authors:  Rubén Burgos-Vargas
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

8.  The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist.

Authors:  Ruben Burgos-Vargas
Journal:  Pediatr Rheumatol Online J       Date:  2012-05-31       Impact factor: 3.054

9.  Identification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment Response.

Authors:  Antoine Obry; Julie Hardouin; Thierry Lequerré; Frédérique Jarnier; Olivier Boyer; Patrice Fardellone; Peggy Philippe; Christian Marcelli; Xavier Le Loët; Olivier Vittecoq; Pascal Cosette
Journal:  Theranostics       Date:  2015-08-09       Impact factor: 11.556

10.  Prevalence of Rheumatoid Arthritis and Spondyloarthritis in Turkey: A Nationwide Study.

Authors:  Tiraje Tuncer; Erdal Gilgil; Cahit Kaçar; Yeşim Kurtaiş; Şehim Kutlay; Bülent Bütün; Peyman Yalçin; Ülkü Akarirmak; Lale Altan; Füsun Ardiç; Özge Ardiçoğlu; Zuhal Altay; Ferhan Cantürk; Lale Cerrahoğlu; Remzi Çevik; Hüseyin Demir; Berrin Durmaz; Nigar Dursun; Tuncay Duruöz; Canan Erdoğan; Deniz Evcik; Savaş Gürsoy; Sami Hizmetli; Ece Kaptanoğlu; Önder Kayhan; Mehmet Kirnap; Siranuş Kokino; Erkan Kozanoğlu; Banu Kuran; Kemal Nas; Sema Öncel; Dilşad Sindel; Sevim Orkun; Tunay Sarpel; Serpil Savaş; Ömer Faruk Şendur; Kazım Şenel; Hatice Uğurlu; Kaan Uzunca; İbrahim Tekeoğlu; Francis Guillemin
Journal:  Arch Rheumatol       Date:  2017-10-13       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.